↓ Skip to main content

U0126: Not only a MAPK kinase inhibitor

Overview of attention for article published in Frontiers in Pharmacology, August 2022
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (65th percentile)
  • High Attention Score compared to outputs of the same age and source (87th percentile)

Mentioned by

twitter
1 X user
wikipedia
1 Wikipedia page

Citations

dimensions_citation
13 Dimensions

Readers on

mendeley
30 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
U0126: Not only a MAPK kinase inhibitor
Published in
Frontiers in Pharmacology, August 2022
DOI 10.3389/fphar.2022.927083
Pubmed ID
Authors

Yijie You, Yunlian Niu, Jian Zhang, Sheng Huang, Peiyuan Ding, Fengbing Sun, Xuhui Wang

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 30 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 30 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 5 17%
Unspecified 1 3%
Student > Bachelor 1 3%
Researcher 1 3%
Student > Master 1 3%
Other 0 0%
Unknown 21 70%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 5 17%
Unspecified 1 3%
Agricultural and Biological Sciences 1 3%
Neuroscience 1 3%
Engineering 1 3%
Other 0 0%
Unknown 21 70%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 October 2023.
All research outputs
#7,968,650
of 24,666,614 outputs
Outputs from Frontiers in Pharmacology
#3,597
of 18,718 outputs
Outputs of similar age
#144,193
of 421,889 outputs
Outputs of similar age from Frontiers in Pharmacology
#168
of 1,419 outputs
Altmetric has tracked 24,666,614 research outputs across all sources so far. This one has received more attention than most of these and is in the 67th percentile.
So far Altmetric has tracked 18,718 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.2. This one has done well, scoring higher than 79% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 421,889 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 65% of its contemporaries.
We're also able to compare this research output to 1,419 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 87% of its contemporaries.